Fenbendazole has real preclinical anti-cancer evidence — but zero completed human RCTs as of July 2026 and documented liver injury cases. This complete guide covers the Joe Tippens pembrolizumab confound, Korean n=78 study, 2 Phase I registered trials, the tubulin and glucose mechanism, a full 9-row evidence table, and what patients must tell their oncologist before using it.